Complex Biologics Development – Bispecific Fusion Nanobody CLD Case Study

Access our latest cell line development case study on a VHH camelid nanobody with cytokine fusion for a clinical-stage life sciences company dedicated to the development of conditionally acting medicines for cancer and other diseases. This case study explores how our streamlined and fully integrated cell line development platform, AbZelectPRO, delivered a highly stable, high-producing cell line for their bispecific program, all within a single organization.

Download the case study to learn more: